|
Effect of the loss of NF1 in breast cancer on pathway activation. |
|
|
No Relationships to Disclose |
|
|
Patents, Royalties, Other Intellectual Property - Rush University (Inst) |
|
|
No Relationships to Disclose |
|
|
Employment - Medline Industries (I) |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Roche/Genentech |
Research Funding - Array BioPharma; Macrogenics; Roche/Genentech |
Patents, Royalties, Other Intellectual Property - Genomic Health |
Other Relationship - Puma Biotechnology; Roche/Genentech |